{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:04:50Z","timestamp":1790517890606,"version":"4.1.0"},"reference-count":55,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.3892\/etm.2016.3169","type":"journal-article","created":{"date-parts":[[2016,3,15]],"date-time":"2016-03-15T11:18:28Z","timestamp":1458040708000},"page":"1625-1632","source":"Crossref","is-referenced-by-count":19,"title":["Protective role of adenovirus vector-mediated interleukin-10 gene therapy on endogenous islet \u03b2-cells in recent-onset type 1 diabetes in NOD mice"],"prefix":"10.3892","volume":"11","author":[{"given":"CHENG","family":"LI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LIJUAN","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YANYAN","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XIAOJIE","family":"LIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TANG","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2016,3,15]]},"reference":[{"key":"key20180108123219_b1-etm-0-0-3169","first-page":"943","article-title":"Insulin replacement therapy in patients with type 1 diabetes by isolated pancreatic islet transplantation","volume":"70","author":"Poradzka","year":"2013","journal-title":"Acta Pol Pharm"},{"issue":"Suppl 2","key":"key20180108123219_b2-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.2337\/diabetes.54.suppl_2.S97","article-title":"Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: Many differences, few similarities","volume":"54","author":"Cnop","year":"2005","journal-title":"Diabetes"},{"key":"key20180108123219_b3-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3389\/fendo.2013.00162","article-title":"Immune mechanisms in atherosclerosis, especially in diabetes type 2","volume":"4","author":"Frosteg\u00e5rd","year":"2013","journal-title":"Front Endocrinol (Lausanne)"},{"key":"key20180108123219_b4-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1900\/RDS.2005.2.182","article-title":"Imbalance in Th cell polarization and its relevance in type 1 diabetes mellitus","volume":"2","author":"Sia","year":"2005","journal-title":"Rev Diabet Stud"},{"key":"key20180108123219_b5-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0167-5699(96)80606-2","article-title":"The expanding universe of T-cell subsets: Th1, Th2 and more","volume":"17","author":"Mosmann","year":"1996","journal-title":"Immunol Today"},{"key":"key20180108123219_b6-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2337\/diabetes.45.6.749","article-title":"Cytokine gene expression in pancreatic islet-infiltrating leukocytes of BB rats: Expression of Th1 cytokines correlates with beta-cell destructive insulitis and IDDM","volume":"45","author":"Rabinovitch","year":"1996","journal-title":"Diabetes"},{"key":"key20180108123219_b7-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/j.1464-5491.2012.03710.x","article-title":"Decreased GAD(65)-specific Th1\/Tc1 phenotype in children with Type 1 diabetes treated with GAD-alum","volume":"29","author":"Axelsson","year":"2012","journal-title":"Diabet Med"},{"key":"key20180108123219_b8-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2165\/00148581-200305090-00001","article-title":"Vaccine therapies for the prevention of type 1 diabetes mellitus","volume":"5","author":"Petrovsky","year":"2003","journal-title":"Paediatr Drugs"},{"key":"key20180108123219_b9-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.1210\/jcem.86.10.7938","article-title":"Th2 cytokines have a partial, direct protective effect on the function and survival of isolated human islets exposed to combined proinflammatory and Th1 cytokines","volume":"86","author":"Marselli","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180108123219_b10-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1084\/jem.174.4.915","article-title":"Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression","volume":"174","author":"de Waal Malefyt","year":"1991","journal-title":"J Exp Med"},{"key":"key20180108123219_b11-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"G820","DOI":"10.1152\/ajpgi.00438.2005","article-title":"IL-10 protects mouse intestinal epithelial cells from Fas-induced apoptosis via modulating Fas expression and altering caspase-8 and FLIP expression","volume":"291","author":"Bharhani","year":"2006","journal-title":"Am J Physiol Gastrointest liver Physiol"},{"key":"key20180108123219_b12-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ajpath.2011.04.016","article-title":"Inhibition of Fas ligand in NOD mice unmasks a protective role for IL-10 against insulitis development","volume":"179","author":"Xiao","year":"2011","journal-title":"Am J Pathol"},{"key":"key20180108123219_b13-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0140-6736(98)85018-6","article-title":"Haplotype associated with low interleukin-10 production in patients with severe asthma","volume":"352","author":"Lim","year":"1998","journal-title":"Lancet"},{"key":"key20180108123219_b14-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"838390","DOI":"10.1155\/2010\/838390","article-title":"IL-10 and TNFalpha genotypes in SLE","volume":"2010","author":"L\u00f3pez","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"key20180108123219_b15-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00006676-200003000-00013","article-title":"Cytokine balance and lipid antigen presentation in the NOD mouse pancreas during development of insulitis","volume":"20","author":"Teros","year":"2000","journal-title":"Pancreas"},{"key":"key20180108123219_b16-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1464-5491.2011.03544.x","article-title":"Hvidoere Study Group on Childhood Diabetes: Association between age, IL-10, IFN\u03b3, stimulated C-peptide and disease progression in children with newly diagnosed Type 1 diabetes","volume":"29","author":"Kaas","year":"2012","journal-title":"Diabet Med"},{"key":"key20180108123219_b17-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jconrel.2012.05.041","article-title":"PEGylation of interleukin-10 improves the pharmacokinetic profile and enhances the antifibrotic effectivity in CCl4-induced fibrogenesis in mice","volume":"162","author":"Mattos","year":"2012","journal-title":"J Control Release"},{"key":"key20180108123219_b18-etm-0-0-3169","first-page":"1711","article-title":"Effects of adenovirus mediated interleukin-10 gene transfer on apoptosis and insulin secretion function of beta cell","volume":"90","author":"Xu","year":"2010","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"key20180108123219_b19-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11010-010-0539-x","article-title":"Recombinant adenoviral expression of IL-10 protects beta cell from impairment induced by pro-inflammatory cytokine","volume":"344","author":"Xu","year":"2010","journal-title":"Mol Cell Biochem"},{"key":"key20180108123219_b20-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"6159","DOI":"10.4049\/jimmunol.168.12.6159","article-title":"Regulation of diabetes development by regulatory T cells in pancreatic islet antigen-specific TCR transgenic nonobese diabetic mice","volume":"168","author":"Kanagawa","year":"2002","journal-title":"J Immunol"},{"key":"key20180108123219_b21-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.2337\/db06-0328","article-title":"Expression of IGF-I in pancreatic islets prevents lymphocytic infiltration and protects mice from type 1 diabetes","volume":"55","author":"Casellas","year":"2006","journal-title":"Diabetes"},{"key":"key20180108123219_b22-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.trsl.2012.12.017","article-title":"Mechanistic basis of immunotherapies for type 1 diabetes mellitus","volume":"161","author":"Chen","year":"2013","journal-title":"Transl Res"},{"key":"key20180108123219_b23-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJMoa1107096","article-title":"GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus","volume":"366","author":"Ludvigsson","year":"2012","journal-title":"N Engl J Med"},{"key":"key20180108123219_b24-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.2337\/dc11-0523","article-title":"DPT-1 and TrialNet Study Groups: Long-term outcome of individuals treated with oral insulin: Diabetes prevention trial-type 1 (DPT-1) oral insulin trial","volume":"34","author":"Vehik","year":"2011","journal-title":"Diabetes Care"},{"key":"key20180108123219_b25-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.2337\/dc09-0449","article-title":"NBI-6024 Study Group: No effect of the altered peptide ligand NBI-6024 on beta-cell residual function and insulin needs in new-onset type 1 diabetes","volume":"32","author":"Walter","year":"2009","journal-title":"Diabetes Care"},{"key":"key20180108123219_b26-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0140-6736(11)60931-8","article-title":"Prot\u00e9g\u00e9 Trial Investigators: Teplizumab for treatment of type 1 diabetes (Prot\u00e9g\u00e9 study): 1-Year results from a randomised, placebo-controlled trial","volume":"378","author":"Sherry","year":"2011","journal-title":"Lancet"},{"key":"key20180108123219_b27-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s11892-010-0138-y","article-title":"Link\u00f6ping Diabetes Immune Intervention study group: Immune intervention in children with type 1 diabetes","volume":"10","author":"Ludvigsson","year":"2010","journal-title":"Curr Diab Rep"},{"key":"key20180108123219_b28-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"key20180108123219_b29-etm-0-0-3169","first-page":"85","article-title":"Interleukin-10: Effects on phagocytosis and adhesion molecule expression of granulocytes and monocytes in a comparison with prednisolone","volume":"4","author":"Buchwald","year":"1999","journal-title":"Eur J Med Res"},{"key":"key20180108123219_b30-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1084\/jem.174.5.1209","article-title":"Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes","volume":"174","author":"de Waal Malefyt","year":"1991","journal-title":"J Exp Med"},{"key":"key20180108123219_b31-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.4049\/jimmunol.147.11.3815","article-title":"IL-10 inhibits cytokine production by activated-macrophages","volume":"147","author":"Fiorentino","year":"1991","journal-title":"J Immunol"},{"key":"key20180108123219_b32-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nature04369","article-title":"Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6","volume":"439","author":"H\u00e4cker","year":"2006","journal-title":"Nature"},{"key":"key20180108123219_b33-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.4049\/jimmunol.159.10.4772","article-title":"Induction of tolerance by IL-10-treated dendritic cells","volume":"159","author":"Steinbrink","year":"1997","journal-title":"J Immunol"},{"key":"key20180108123219_b34-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1182\/blood.V93.5.1634","article-title":"Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells","volume":"93","author":"Steinbrink","year":"1999","journal-title":"Blood"},{"key":"key20180108123219_b35-etm-0-0-3169","first-page":"1","article-title":"Viral vectors: A look back and ahead on gene transfer technology","volume":"36","author":"Vannucci","year":"2013","journal-title":"New Microbiol"},{"key":"key20180108123219_b36-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2337\/diabetes.48.4.745","article-title":"Gene transfer to human pancreatic endocrine cells using viral vectors","volume":"48","author":"Leibowitz","year":"1999","journal-title":"Diabetes"},{"key":"key20180108123219_b37-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00007890-199501270-00019","article-title":"Efficient gene transfer to pancreatic islets mediated by adenoviral vectors","volume":"59","author":"Csete","year":"1995","journal-title":"Transplantation"},{"key":"key20180108123219_b38-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1084\/jem.170.6.2081","article-title":"Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones","volume":"170","author":"Fiorentino","year":"1989","journal-title":"J Exp Med"},{"key":"key20180108123219_b39-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1056\/NEJM198605223142106","article-title":"Type I diabetes mellitus. A chronic autoimmune disease","volume":"314","author":"Eisenbarth","year":"1986","journal-title":"N Engl J Med"},{"key":"key20180108123219_b40-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/10408361003787171","article-title":"Autoimmunity and the pathogenesis of type 1 diabetes","volume":"47","author":"Csorba","year":"2010","journal-title":"Crit Rev Clin Lab Sci"},{"key":"key20180108123219_b41-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"E50","DOI":"10.1152\/ajpendo.00596.2005","article-title":"Activation of the Reg family genes by pancreatic-specific IGF-I gene deficiency and after streptozotocin-induced diabetes in mouse pancreas","volume":"291","author":"Lu","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"key20180108123219_b42-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1074\/jbc.M110.162131","article-title":"STAT1 is a master regulator of pancreatic {beta}-cell apoptosis and islet inflammation","volume":"286","author":"Moore","year":"2011","journal-title":"J Biol Chem"},{"key":"key20180108123219_b43-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"6637","DOI":"10.4049\/jimmunol.167.11.6637","article-title":"IFN-gamma affects homing of diabetogenic T cells","volume":"167","author":"Savinov","year":"2001","journal-title":"J Immunol"},{"key":"key20180108123219_b44-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1084\/jem.178.1.87","article-title":"Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice","volume":"178","author":"Rapoport","year":"1993","journal-title":"J Exp Med"},{"key":"key20180108123219_b45-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1084\/jem.184.3.1093","article-title":"Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice","volume":"184","author":"Mueller","year":"1996","journal-title":"J Exp Med"},{"key":"key20180108123219_b46-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.4049\/jimmunol.163.3.1696","article-title":"Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse","volume":"163","author":"Gallichan","year":"1999","journal-title":"J Immunol"},{"key":"key20180108123219_b47-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.4049\/jimmunol.157.10.4690","article-title":"Decreased IL-4 production in new onset type I insulin-dependent diabetes mellitus","volume":"157","author":"Berman","year":"1996","journal-title":"J Immunol"},{"key":"key20180108123219_b48-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/mt.2008.116","article-title":"AAV8-mediated gene transfer of interleukin-4 to endogenous beta-cells prevents the onset of diabetes in NOD mice","volume":"16","author":"Rehman","year":"2008","journal-title":"Mol Ther"},{"key":"key20180108123219_b49-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2741\/E609","article-title":"C-peptide in diabetes diagnosis and therapy","volume":"5","author":"Ludvigsson","year":"2013","journal-title":"Front Biosci (Elite Ed)"},{"key":"key20180108123219_b50-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1042\/CS20080441","article-title":"Cellular and physiological effects of C-peptide","volume":"116","author":"Hills","year":"2009","journal-title":"Clin Sci (Lond)"},{"key":"key20180108123219_b51-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1159\/000289864","article-title":"C-peptide as a therapeutic tool in diabetic nephropathy","volume":"31","author":"Hills","year":"2010","journal-title":"Am J Nephrol"},{"key":"key20180108123219_b52-etm-0-0-3169","first-page":"976","article-title":"Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1","volume":"77","author":"Johansson","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180108123219_b53-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2337\/diabetes.52.2.536","article-title":"Amelioration of sensory nerve dysfunction by C-Peptide in patients with type 1 diabetes","volume":"52","author":"Ekberg","year":"2003","journal-title":"Diabetes"},{"key":"key20180108123219_b54-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.2337\/diabetes.52.7.1812","article-title":"Effects of proinsulin C-peptide in experimental diabetic neuropathy: Vascular actions and modulation by nitric oxide synthase inhibition","volume":"52","author":"Cotter","year":"2003","journal-title":"Diabetes"},{"key":"key20180108123219_b55-etm-0-0-3169","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1042\/CS20020291","article-title":"Residual C-peptide secretion and endothelial function in patients with Type II diabetes","volume":"105","author":"Manzella","year":"2003","journal-title":"Clin Sci (Lond)"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/etm.2016.3169\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T06:47:52Z","timestamp":1692254872000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2016.3169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,15]]},"references-count":55,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,3,15]]},"published-print":{"date-parts":[[2016,5]]}},"alternative-id":["10.3892\/etm.2016.3169"],"URL":"https:\/\/doi.org\/10.3892\/etm.2016.3169","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,15]]}}}